Evidence map›Paper›PMID 42390865›Full record

ArticleJAMA network open2026

Urbanicity, Neighborhood Conditions, and Dementia Mortality.

Shujuan Chen, Yue Li, Ying Jin

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shujuan ChenMartin Centre for Architectural and Urban Studies, University of Cambridge, Cambridge, United Kingdom.
Yue LiMartin Centre for Architectural and Urban Studies, University of Cambridge, Cambridge, United Kingdom.
Ying JinMartin Centre for Architectural and Urban Studies, University of Cambridge, Cambridge, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: As populations age and cities become more densely populated, urbanicity is transforming neighborhood environments that influence healthy aging. However, how dementia mortality varies across the urbanicity gradient and how neighborhood conditions contribute to this pattern remain unknown. Objective: To examine dose-response associations of urbanicity with dementia mortality, quantify the extent to which neighborhood socioeconomic and environmental factors attenuate this pattern, and estimate potential deaths averted under feasible improvements in modifiable conditions. Design, Setting, and Participants: This prospective cohort study used person-level mortality data linked to the national census across 32 844 lower super output areas (ie, small census-based geographic areas) in England from March 2011 to February 2023. Individuals aged 16 years and older with National Health Service general practice registration in England were included. Data were analyzed from July 2025 to January 2026. Exposure: Participants' residential addresses were linked to UK Census-based social and environmental data. Urbanicity was defined as neighborhood population density (persons per hectare), and neighborhood conditions included income, employment, education, crime, living environment, housing, and service accessibility. Main Outcomes and Measures: The primary outcome was mortality with dementia as the underlying cause, and the secondary outcome was mortality with dementia mentioned anywhere on the death certificate. Dose-response associations were examined using Cox proportional hazards models with hazard ratios and 95% CIs. Contribution of neighborhood conditions to these associations was assessed using the percentage of excess risk attenuated. Potential death averted under feasible improvements were estimated using parametric g-computation. Results: A total of 40 948 445 individuals (mean [SD] age, 46.9 [19.3] years, 21 263 986 females [51.9%]; 1 190 069 Black [2.9%]; 1 091 312 Indian [2.7%]; 35 973 092 White [87.9%]) were followed up for a median (IQR) of 8.68 (4.47-11.90) years. There were 5 309 719 deaths, including 621 756 underlying-cause and 926 502 any-mention dementia deaths. Dementia mortality showed a curvilinear inverted U-shaped association with urbanicity, peaking at mid-urbanicity (around 20 to 40 persons per hectare) and declining at both extremes. This pattern was consistent across subgroups, dementia subtypes, and all-cause mortality. For mortality with dementia as the underlying cause, adjustment for all factors largely eliminated the gradient (≥71% attenuated), with accessibility and living environment contributing the most. Scenario analyses shifting both service accessibility and outdoor living environment from the lowest to the second quintile estimated 65 572 (95% CI, 42 036-88 783) dementia deaths averted (10.5% reduction), compared with 43 452 (95% CI, 24 214-62 775) deaths averted (7.0% reduction) for accessibility-only, and 22 700 (95% CI, 11 086-34 201) deaths averted (3.7% reduction) for living environment-only improvements. Estimated gains were larger in males, adults aged 45 to 54 years, residents of private households (vs residents of care homes), and Black residents living under a scenario of improvement to both accessibility and environment. Conclusions and Relevance: In this cohort study, dementia mortality risk was greatest in mid-urbanicity and lower in dense urban cores and rural areas, and this gradient was largely attenuated by neighborhood conditions. These findings suggest that targeted improvements in modifiable neighborhood conditions may substantially reduce dementia mortality and advance equity, particularly in vulnerable communities.

Indexed as

DementiaNeighborhood CharacteristicsResidence CharacteristicsUrban PopulationAgedAged, 80 and overEnglandFemaleHumansMaleProportional Hazards ModelsProspective StudiesSocioeconomic Disparities in HealthSocioeconomic Factors

Identifiers

PMID42390865
PMCPMC13329714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.